Life Science Filtration Global Market - Forecast To 2028

Publishing Date : March, 2022
Report Code : HCBT0118
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Filtration is a mechanical or physical process that typically removes unwanted materials from fluids (liquids or gases) by passing only the fluid through a media. Filters have been widely used in life science industries (Pharmaceutical & biopharmaceutical, research and medical device). The process is an essential step in drug discovery development, manufacturing and final processing of both small molecules and large molecules. Contaminant removal, controlling the amount of bioburden during the process, preventing environmental (airborne) contaminants and sterilizing filtration of the final product are the application of filters in pharma industries. In biopharma industries, filters are used both in upstream processing such as media preparation, cell culture and harvesting and in downstream processing such as buffer preparation, concentration/diafiltration and sterile filtration. In medical device industry, filtration is used as an essential component of some of the medical procedures such as hemodialysis, plasmapheresis, ventilation, ECMO, infusion etc and also used in sample preparation for diagnostic tests. Apart from these applications, filtration is commonly employed in research for sterile filtration, particle removal and ultracleaning in cell culture purposes, sample preparation and reagents preparation for laboratory experiments. The systems, consumables (filters) and accessories are necessary to perform filtration process. The choice of right filters is important to use in various applications in pharma, biopharma, medical devices and research as it make a huge difference in yields, process economics and product viability.

The life science filtration global market is expected to grow at a double digit CAGR from 2021 to 2028 to reach $23,684.5 million by 2028. The factors such as growing demand for biologics, increasing investment in research and development (R&D) and expansion of manufacturing facilities, demand for generic pharmaceuticals, rapid growth of medtech industry with increasing disease population, are driving the market, Whereas increasing utilization single use technologies and advancements in filtration technologies such as  development of high capacity membrane filters, changes in pleated geometry, development of advanced pumps and ultrasonic sensor, advancement in membrane technologies and TFF process technologies are providing immense growth opportunities to the market. The high cost of filtration devices, complications associated with filtration and stringent regulations associated with pharma manufacturing and medical device industry are hindering the market growth.

The market for life science filtration is segmented based on products, application, end-user and geography. Based on the products, the market is segmented into filtration systems, consumables and accessories. Among products, filtration consumables segment accounted for the highest revenue in 2021 and is expected to grow at a double digit CAGR from 2021 to 2028. The consumables is further segmented based on filter type and based on filter usage. Based On filter type, the consumables market is segmented into membrane filters and depth filters. Among the filter type, membrane filters segment accounted for the highest revenue in 2021 and is expected to grow at a double digit CAGR from 2021 to 2028. The membrane filters is further segmented based on technology into microfiltration, ultrafiltration and others. Among these, ultrafiltration segment accounted for the highest revenue in 2021 and is expected to grow at a double digit CAGR from 2021 to 2028. Microfiltration is expected to grow at a low teen CAGR from 2021 to 2028. Based on Filter Usage, Consumables are further segmented into reusable filtration and single use filtration. Among these, reusable filtration is accounted for the highest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Single-Use filtration is expected to grow at a low teen CAGR from 2021 to 2028. The filtration systems global market is further segmented into Direct Flow System (DFF), Tangential Flow System (TFF) and others. Among these, Direct Flow System (DFF) segment accounted for the highest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Tangential Flow System (TFF) is expected to grow at a double digit CAGR from 2021 to 2028.

Based on applications the life science filtration global market is divided into drug discovery, development and manufacturing, final processing, medical device and others. Among the applications, drug discovery, development and manufacturing, accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028. Drug discovery, development and manufacturing segment is further segmented based on molecule into small molecule filtration and large molecule filtration. Among these, large molecule filtration segment is accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028.

Based on end users, life science filtration market is segmented into Pharma, Biotech and CMO’s, Hospitals, Diagnostic labs & Dialysis Centers and Others. Among these, Pharma, Biotech and CMO’s segment is accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028.

By geography, the life science filtration global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and the Rest of the world (Brazil, Rest of Latin America and the Middle East & Africa). North America accounted for the largest revenue in 2021 and is expected to grow at a double digit CAGR from 2021 to 2028. The factors such as increasing health care expenditure, growing pharma R&D expenditure, increasing development of new drugs over the time, growing biopharmaceutical drugs pipelines, presence of number of API manufacturing facilities  for all regulated drug products, government support to expand the domestic pharmaceutical manufacturing facilities  increasing generics drug approvals, growing medical device industry, rising chronic kidney disease population with increasing dialysis procedures, and adoption of advanced single use technologies by the filtration companies are driving the life science filtration market in the region.

Asia-Pacific is expected to grow at a double digit CAGR from 2021 to 2028 to reach $XX million by 2028. The factors such as increasing generic pharmaceuticals and vaccines production, number of pharma companies with a strong network of manufacturing facilities, increasing outsourcing with number of CMO’s and expanding manufacturing facilities , increasing development of new pharma and biopharma drugs, growing biotech R&D investment, presence of number of innovative biotech startups, presence of dedicated departments to support biotechnology research, increasing government investment to support the pharma and biotech industry, increasing end-stage kidney disease population with demand for dialysis procedures and raising investment by the filtration company to expand their capabilities are driving the life science filtration market in the region.

The life science filtration global market is competitive and all the players in this market are involved in adopting advanced technologies in life science filtration to expand their product portfolio and maintain their market shares.

The key players in the life science filtration global market include 3M Company (U.S.), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Danaher Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Merck KGaA (Germany), Nipro Corporation (Japan), Parker-Hannifin Corporation (U.S.), Repligen Corporation (U.S.), and Sartorius (Germany)

The report provides an in-depth market analysis of the above-mentioned segments across the following region:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • Italy
  • France
  • Rest of Europe
  • Asia-Pacific 
  • China
  • Japan
  • India
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East and Others
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.5     PRIMARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     Growing demand for biologics
        • 3.3.1.2     Increasing investment in research and development (R&D) and expansion of manufacturing facilities
        • 3.3.1.3     Demand for generic pharmaceuticals
        • 3.3.1.4     Growing medtech industry with increasing disease population
        • 3.3.1.5     Increasing use of single-use technologies
        • 3.3.1.6     Advancements in filtration technologies
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     Lack of skilled personnel
        • 3.3.2.2     Contamination related issues and high cost associated with filtration device
        • 3.3.2.3     Compliance with stringent regulatory guidelines
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     UNITED STATES
      • 3.4.2     EUROPE
      • 3.4.3     JAPAN
      • 3.4.4     CHINA
      • 3.4.5     INDIA
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     BARGAINING POWER OF SUPPLIERS
      • 3.5.4     BARGAINING POWER OF BUYERS
      • 3.5.5     COMPETITIVE RIVALRY
    • 3.6     SUPPLY CHAIN ANALYSIS
    • 3.7     PATENT ANALYSIS
    • 3.8     TECHNOLOGICAL ADVANCEMENTS
      • 3.8.1     INTRODUCTION
      • 3.8.2     ADVANCEMENT IN PLEATED DESIGNS OF FILTER
      • 3.8.3     ADVANCEMENT IN TANGENTIAL FLOW FILTRATION PROCESS OR TECHNOLOGY
      • 3.8.4     ADVANCEMENT MEMBRANE TECHNOLOGY
    • 3.9     IMPACT OF COVID-19 ON LIFE SCIENCE FILTRATION MARKET
    • 3.1     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
  • 4     LIFE SCIENCE FILTRATION GLOBAL MARKET, BASED ON PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     FILTRATION SYSTEMS
      • 4.2.1     DIRECT FLOW SYSTEM (DFF)
      • 4.2.2     TANGENTIAL FLOW SYSTEM (TFF)
      • 4.2.3     OTHERS
    • 4.3     FILTRATION CONSUMABLES
      • 4.3.1     BASED ON FILTER TYPE
        • 4.3.1.1     Membrane filters
          • 4.3.1.1.1      Microfiltration
          • 4.3.1.1.2      Ultrafiltration
          • 4.3.1.1.3      Others
        • 4.3.1.2     Depth filters
      • 4.3.2     BASED ON FILTER USAGE
        • 4.3.2.1     Reusable Filtration
        • 4.3.2.2     Single Use Filtration
    • 4.4     ACESSIORIES
  • 5     LIFE SCIENCE FILTRATION GLOBAL MARKET, BASED ON APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING
      • 5.2.1     SMALL MOLECULE FILTRATION
      • 5.2.2     LARGE MOLECULE FILTRATION
    • 5.3     FINAL PROCESSING
    • 5.4     MEDICAL DEVICES
    • 5.5     OTHERS
  • 6     LIFE SCIENCE FILTRATION GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     PHARMA, BIOTECH AND CMO’S
    • 6.3     HOSPITALS, DIAGNOSTIC LABS & DIALYSIS CENTERS
    • 6.4     OTHERS
  • 7     REGIONAL ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     ITALY
      • 7.3.4     REST OF EUROPE
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     REST OF APAC
    • 7.5     REST OF THE WORLD
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     EXPANSIONS
    • 8.3     ACQUISITIONS
    • 8.4     NEW PRODUCT LAUNCH
    • 8.5     APPORVAL
  • 9     MAJOR COMPANIES
    • 9.1     3M COMPANY
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     ASAHI KASEI CORPORATION
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     BAXTER INTERNATIONAL INC.
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     DANAHER CORPORATION
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     FRESENIUS SE & CO. KGAA
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     MERCK KGAA
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     NIPRO CORPORATION
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUISNESS STRATERGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     PARKER-HANNIFIN CORPORATION
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     REPLIGEN CORPORATION
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.1     SARTORIUS
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     LIFE SCIENCE FILTRATION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 2     LIFE SCIENCE FILTRATION GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2020-2028) ($MN)
      • TABLE 3     FILTRATION YSTEMS GLOBAL MARKET REVENUE, BASED ON TYPE, (2020-2028) ($MN)
      • TABLE 4     FILTRATION SYSTEMS MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 5     DIRECT FLOW SYSTEM (DFF) MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 6     TANGENTIAL FLOW SYSTEM (TFF) MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 7     OTHERS MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 8     FILTRATION CONSUMABLES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 9     CONSUMABLES GLOBAL MARKET REVENUE, BASED ON FILTER TYPE, (2020-2028) ($MN)
      • TABLE 10     MEMBRANE FILTERS GLOBAL MARKET REVENUE, BASED ON TECHNIQUE, (2020-2028) ($MN)
      • TABLE 11     MEMBRANE FILTERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 12     MICROFILTRAION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 13     ULTRAFILTRATION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 14     OTHERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 15     DEPTH FILTERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 16     CONSUMABLES MARKET REVENUE, BASED ON FILTER USAGE, (2020-2028) ($MN)
      • TABLE 17     REUSABLE FILTRATION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 18     SINGLE USE FILTRATION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 19     ACCESSIORIES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 20     LIFE SCIENCE FILTRATION GLOBAL MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 21     DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET REVENUE, BASED ON MOLECULES, (2020-2028) ($MN)
      • TABLE 22     DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 23     SMALL MOLECULE FILTRATION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 24     LARGE MOLECULE FILTRATION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 25     FINAL PROCESSING GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 26     MEDICAL DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 27     OTHERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 28     LIFE SCIENCE FILTRATION GLOBAL MARKET REVENUE, BASED ON END-USERS, (2020-2028) ($MN)
      • TABLE 29     PHARMA, BIOTECH AND CMO’S GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 30     HOSPITALS, DIAGNOSTIC LABS & DIALYSIS CENTERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 31     OTHERS GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 32     LIFE SCIENCE FILTRATION GLOBAL MARKET REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • TABLE 33     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS (2020-2028) ($MN)
      • TABLE 34     NORTH AMERICA FILTRATION SYSTEMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
      • TABLE 35     NORTH AMERICA CONSUMABLES MARKET REVENUE, BASED ON FILTER TYPE (2020-2028) ($MN)
      • TABLE 36     NORTH AMERICA MEMBRANE FILTERS MARKET REVENUE, BASED ON TECHNIQUE (2020-2028) ($MN)
      • TABLE 37     NORTH AMERICA CONSUMABLES MARKET REVENUE, BASED ON FILTER USAGE (2020-2028) ($MN)
      • TABLE 38     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 39     NORTH AMERICA DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET REVENUE, BASED ON MOLECULE, (2020-2028) ($MN)
      • TABLE 40     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
      • TABLE 41     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
      • TABLE 42     EUROPE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS (2020-2028) ($MN)
      • TABLE 43     EUROPE FILTRATION SYSTEMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
      • TABLE 44     EUROPE CONSUMABLES MARKET REVENUE, BASED ON FILTER TYPE (2020-2028) ($MN)
      • TABLE 45     EUROPE MEMBRANE FILTERS MARKET REVENUE, BASED ON TECHNIQUE (2020-2028) ($MN)
      • TABLE 46     EUROPE CONSUMABLES MARKET REVENUE, BASED ON FILTER USAGE (2020-2028) ($MN)
      • TABLE 47     EUROPE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 48     EUROPE DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET REVENUE, BASED ON MOLECULE, (2020-2028) ($MN)
      • TABLE 49     EUROPE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
      • TABLE 50     EUROPE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
      • TABLE 51     APAC LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS (2020-2028) ($MN)
      • TABLE 52     APAC FILTRATION SYSTEMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
      • TABLE 53     APAC CONSUMABLES MARKET REVENUE, BASED ON FILTER TYPE (2020-2028) ($MN)
      • TABLE 54     APAC MEMBRANE FILTERS MARKET REVENUE, BASED ON TECHNIQUE (2020-2028) ($MN)
      • TABLE 55     APAC CONSUMABLES MARKET REVENUE, BASED ON FILTER USAGE (2020-2028) ($MN)
      • TABLE 56     APAC LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 57     APAC DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET REVENUE, BASED ON MOLECULE, (2020-2028) ($MN)
      • TABLE 58     APAC LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
      • TABLE 59     APAC LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
      • TABLE 60     ROW LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS (2020-2028) ($MN)
      • TABLE 61     ROW FILTRATION SYSTEMS MARKET REVENUE, BASED ON TYPE (2020-2028) ($MN)
      • TABLE 62     ROW CONSUMABLES MARKET REVENUE, BASED ON FILTER TYPE (2020-2028) ($MN)
      • TABLE 63     ROW MEMBRANE FILTERS MARKET REVENUE, BASED ON TECHNIQUE (2020-2028) ($MN)
      • TABLE 64     ROW CONSUMABLES MARKET REVENUE, BASED ON FILTER USAGE (2020-2028) ($MN)
      • TABLE 65     ROW LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON APPLICATION, (2020-2028) ($MN)
      • TABLE 66     ROW DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET REVENUE, BASED ON MOLECULE, (2020-2028) ($MN)
      • TABLE 67     ROW LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER, (2020-2028) ($MN)
      • TABLE 68     ROW LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON COUNTRY (2020-2028) ($MN)
      • TABLE 69     ACQUISITION (2020 – 2021)
      • TABLE 70     NEW PRODUCT LAUNCH (2020 – 2021)
      • TABLE 71     3M COMPANY : TOTAL REVENUE AND R&D EXPENSES, (2020-2021) ($MN)
      • TABLE 72     3M COMPANY : TOTAL REVENUE, BY SEGMENTS, (2020-2021)($MN)
      • TABLE 73     3M COMPANY : TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)
      • TABLE 74     ASAHI KASEI CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) (Q3) ($MN)
      • TABLE 75     ASAHI KASEI CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2020-2021) (Q3) ($MN)
      • TABLE 76     ASAHI KASEI CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) (Q3) ($MN)
      • TABLE 77     BAXTER INTERNATIONAL INC.: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) ($MN)
      • TABLE 78     BAXTER INTERNATIONAL INC. : TOTAL REVENUE, BY SEGMENTS, (2020-2021) ($MN)
      • TABLE 79     BAXTER INTERNATIONAL INC.: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)
      • TABLE 80     DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) ($MN)
      • TABLE 81     DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2020-2021) ($MN)
      • TABLE 82     DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)
      • TABLE 83     FRESENIUS SE & CO. KGAA: TOTAL REVENUE AND R&D EXPENSES (2020-2021) ($MN)
      • TABLE 84     FRESENIUS SE & CO. KGAA: TOTAL REVENUE, BY SEGMENT, (2020-2021) ($MN)
      • TABLE 85     FRESENIUS SE & CO. KGAA: TOTAL REVENUE, BY GEOGRAPHY (2019-2021) ($MN)
      • TABLE 86     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) ($MN)
      • TABLE 87     MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2020-2021)($MN)
      • TABLE 88     MERCK KGAA: TOTAL REVENUE, BY SUB-SEGMENTS, (2020-2021) ($MN)
      • TABLE 89     MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)
      • TABLE 90     NIPRO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2020-2021) ($MN)
      • TABLE 91     NIPRO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2020-2021)($MN)
      • TABLE 92     NIPRO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)
      • TABLE 93     PARKER-HANNIFIN CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2021-2022) (Q2) ($MN)
      • TABLE 94     PARKER-HANNIFIN CORPORATION: TOTAL REVENUE, BY SEGMENT, (2021-2022)(Q2) ($MN)
      • TABLE 95     PARKER-HANNIFIN CORPORATION: TOTAL REVENUE, BY SUB-SEGMENT, (2021-2022)(Q2) ($MN)
      • TABLE 96     PARKER-HANNIFIN CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)
      • TABLE 97     REPLIGEN CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2020-2021) ($MN)
      • TABLE 98     REPLIGEN CORPORATION: TOTAL REVENUE, BY SEGMENT, (2020-2021) ($MN)
      • TABLE 99     REPLIGEN CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)
      • TABLE 100     SARTORIUS: TOTAL REVENUE AND R&D EXPENSES (2020-2021) ($MN)
      • TABLE 101     SARTORIUS: TOTAL REVENUE, BY SEGMENT, (2020-2021) ($MN)
      • TABLE 102     SARTORIUS: TOTAL REVENUE, BY GEOGRAPHY, (2020-2021) ($MN)

      LIST OF FIGURES

      • FIGURE 1     LIFE SCIENCE FILTRATION GLOBAL MARKET SHARE AND REVENUE, BASED ON REGION, (2020-2028) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: LIFE SCIENCE FILTRATION GLOBAL MARKET
      • FIGURE 3     LIFE SCIENCE FILTRATIONGLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     LIFE SCIENCE FILTRATION GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     LIFE SCIENCE FILTRATION: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     LIFE SCIENCE FILTRATION GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     LIFE SCIENCE FILTRATION GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     LIFE SCIENCE FILTRATION GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     LIFE SCIENCE FILTRATION MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2021)
      • FIGURE 11     LIFE SCIENCE FILTRATIONGLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2021)
      • FIGURE 12     LIFE SCIENCE FILTRATION GLOBAL MARKET SHARE, BASED ON PRODUCTS, CONSUMABLES AND SYSTEM TYPE (2021) (%)
      • FIGURE 13     OTHERS GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 14     FILTRATION CONSUMABLES GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 15     MEMBRANE FILTERS GLOBAL MARKET SHARE, BASED ON TECHNIQUE, (2021 VS 2028) (%)
      • FIGURE 16     MEMBRANE FILTERS GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 17     MICROFILTRAION GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 18     ULTRAFILTRATION GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 19     DEPTH FILTERS GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 20     CONSUMABLES GLOBAL MARKET SHARE, BASED ON FILTER USAGE, (2021 V/S 2028) (%)
      • FIGURE 21     REUSABLE FILTRATION GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 22     SINGLE USE FILTRATION GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 23     ACCESSIORIES GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 24     LIFE SCIENCE FILTRATION GLOBAL MARKET SHARE, BASED ON APPLICATION, (2021 V/S 2028) (%)
      • FIGURE 25     DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET SHARE, BASED ON MOLECULES, (2021 V/S 2028) (%)
      • FIGURE 26     DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 27     SMALL MOLECULE FILTRATION GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 28     LARGE MOLECULE FILTRATION GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 29     MEDICAL DEVICES GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 30     MEDICAL DEVICES GLOBAL MARKET SHARE AND REVENUE, BASED ON TYPE, (2021 VS 2028) ($ MN) (%)
      • FIGURE 31     OTHERS GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 32     LIFE SCIENC FILTRATION GLOBAL MARKET SHARE, BASED ON END-USERS, (2021 V/S 2028) (%)
      • FIGURE 33     PHARMA, BIOTECH AND CMO’S GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 34     HOSPITALS, DIAGNOSTIC LABS & DIALYSIS CENTERS GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 35     OTHERS GLOBAL MARKET SHARE, BASED ON REGION, (2021 VS 2028) (%)
      • FIGURE 36     LIFE SCIENCE FILTRATION GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN), CAGR (%)
      • FIGURE 37     LIFE SCIENCE FILTRATION GLOBAL MARKET REVENUE, BY GEOGRAPHY (2021) ($ MN)
      • FIGURE 38     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON PRODUCTS, CONSUMABLES AND SYSTEM TYPE (2021) (%)
      • FIGURE 39     NORTH AMERICA MEMBRANE FILTERS MARKET SHARE, BASED ON TECHNIQUE (2021 VS 2028) (%)
      • FIGURE 40     NORTH AMERICA CONSUMABLES MARKET SHARE, BASED ON FILTER USAGE (2021 VS 2028) (%)
      • FIGURE 41     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
      • FIGURE 42     NORTH AMERICA DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET SHARE, BASED ON MOLECULES (2021 VS 2028) (%)
      • FIGURE 43     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON END-USER (2021 VS 2028) (%)
      • FIGURE 44     NORTH AMERICA LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
      • FIGURE 45     U.S. LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028)($MN)
      • FIGURE 46     U.S. LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028)($MN)
      • FIGURE 47     REST OF NORTH AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS AND APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 48     REST OF NORTH AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 49     EUROPE LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON PRODUCTS, CONSUMABLES AND SYSTEM TYPE (2021) (%)
      • FIGURE 50     EUROPE MEMBRANE FILTERS MARKET SHARE, BASED ON TECHNIQUE (2021 VS 2028) (%)
      • FIGURE 51     EUROPE CONSUMABLES MARKET SHARE, BASED ON FILTER USAGE (2021 VS 2028) (%)
      • FIGURE 52     EUROPE LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
      • FIGURE 53     EUROPE DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET SHARE, BASED ON MOLECULES (2021 VS 2028) (%)
      • FIGURE 54     EUROPE LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON END-USER (2021 VS 2028) (%)
      • FIGURE 55     EUROPE LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
      • FIGURE 56     GERMANY LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 57     GERMANY LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 58     FRANCE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 59     FRANCE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 60     ITALY LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 61     ITALY LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 62     REST OF EUROPE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 63     REST OF EUROPE LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 64     APAC LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON PRODUCTS, CONSUMABLES AND SYSTEM TYPE (2021) (%)
      • FIGURE 65     APAC MEMBRANE FILTERS MARKET SHARE, BASED ON TECHNIQUE (2021 VS 2028) (%)
      • FIGURE 66     APAC CONSUMABLES MARKET SHARE, BASED ON FILTER USAGE (2021 VS 2028) (%)
      • FIGURE 67     APAC LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
      • FIGURE 68     APAC DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET SHARE, BASED ON MOLECULES (2021 VS 2028) (%)
      • FIGURE 69     APAC LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON END-USER (2021 VS 2028) (%)
      • FIGURE 70     APAC LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
      • FIGURE 71     JAPAN LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 72     JAPAN LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 73     CHINA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 74     CHINA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 75     INDIA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 76     INDIA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 77     REST OF APAC COUNTRIES LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION, (2021 VS 2028) ($MN)
      • FIGURE 78     REST OF APAC LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON END-USER (2021 VS 2028) ($MN)
      • FIGURE 79     ROW LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON PRODUCTS, CONSUMABLES AND SYSTEM TYPE (2021) (%)
      • FIGURE 80     ROW MEMBRANE FILTERS MARKET SHARE, BASED ON TECHNIQUE (2021 VS 2028) (%)
      • FIGURE 81     ROW CONSUMABLES MARKET SHARE, BASED ON FILTER USAGE (2021 VS 2028) (%)
      • FIGURE 82     ROW LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON APPLICATION (2021 VS 2028) (%)
      • FIGURE 83     ROW DRUG DISCOVERY, DEVELOPMENT AND MANUFACTURING MARKET SHARE, BASED ON MOLECULES (2021 VS 2028) (%)
      • FIGURE 84     ROW LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON END-USER (2021 VS 2028) (%)
      • FIGURE 85     ROW LIFE SCIENCE FILTRATION MARKET SHARE, BASED ON COUNTRY (2021 V/S 2028) (%)
      • FIGURE 86     BRAZIL LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 87     BRAZIL LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON ENDUSER (2021 VS 2028) ($MN)
      • FIGURE 88     REST OF LATIN AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 89     REST OF LATIN AMERICA LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON ENDUSER (2021 VS 2028) ($MN)
      • FIGURE 90     MIDDLE EAST AND OTHERS LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON PRODUCTS & APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 91     MIDDLE EAST AND OTHERS LIFE SCIENCE FILTRATION MARKET REVENUE, BASED ON ENDUSER (2021 VS 2028) ($MN)
      • FIGURE 92     KEY GROWTH STRATEGIES, (2020 – 2021)
      • FIGURE 93     EXPANSIONS (2020 – 2021)
      • FIGURE 94     SWOT: 3M COMPANY
      • FIGURE 95     SWOT: ASAHI KASEI CORPORATION
      • FIGURE 96     SWOT: BAXTER INTERNATIONAL INC
      • FIGURE 97     SWOT: DANAHER CORPORATION
      • FIGURE 98     SWOT: FRESENIUS SE & CO. KGAA
      • FIGURE 99     SWOT: MERCK KGAA
      • FIGURE 100     SWOT: NIPRO CORPORATION
      • FIGURE 101     SWOT: PARKER-HANNIFIN CORPORATION
      • FIGURE 102     SWOT: REPLIGEN CORPORATION
      • FIGURE 103     SWOT: SARTORIUS

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     Absolute Filter Solutions Pvt Ltd.
      • 2     Advantec MFS
      • 3     Agilitech
      • 4     Alfa Laval AB
      • 5     Allmed Medical Care Holdings Limited
      • 6     Amazon Filters Ltd
      • 7     Asahi Kasei Corporation
      • 8     B. Braun Melsungen AG
      • 9     Bain Medical Equipment
      • 10     Baxter International, Inc.
      • 11     BEA Technologies
      • 12     Brother Filtration
      • 13     Browndove Healthcare (P) Ltd.
      • 14     Clariance Technique
      • 15     Cobetter Filtration
      • 16     CODAN Medizinische Geräte GmbH & Co KG
      • 17     Corning
      • 18     Critical Process Inc
      • 19     Danaher Corporation
      • 20     Dialife SA (Switzerland)
      • 21     Donaldson Company, Inc.
      • 22     Entegris (Hangzhou Anow Microfiltration Co)
      • 23     ErtelAlsop
      • 24     FARMASOL Medical Products Ind. and Trd. Co.,
      • 25     Filter Concept Pvt. Ltd.
      • 26     Filtrox AG
      • 27     Fresenius Medical Care AG and Co. KGaA
      • 28     GEA Group AG
      • 29     Getinge Group
      • 30     GMM Pfaudler Ltd.
      • 31     Gopani Product Systems
      • 32     Graver Technologies
      • 33     GVS Group S.p.A. (GVS Filtration Inc.)
      • 34     HansaBioMed Life Sciences
      • 35     Health Union, LLC (WEGO Healthcare Co., Ltd.)
      • 36     HLE Glascoat Limited
      • 37     HUM GmbH
      • 38     Infomed SA
      • 39     it4ip
      • 40     Jiangsu Jiuwu Hi-Tech Co.,Ltd
      • 41     JIANGSU LENGTHEN LIFE SCIENCE AND TECHNOLOGY CO., LTD
      • 42     Jihua Medical Apparatus and Instruments Co., Ltd.
      • 43     JMS Co.Ltd.
      • 44     Kaneka Corporation
      • 45     KASAG Swiss AG
      • 46     King Filtration Technologies, Inc.
      • 47     Koch Separation Solutions
      • 48     LivaNova PLC
      • 49     MDI Membrane Technologies, Inc.
      • 50     Medica SPA
      • 51     Medtronic plc
      • 52     Meissner Filtration Products, Inc.
      • 53     Membrane Solutions
      • 54     Merck KGaA
      • 55     Microfilt India Pvt. Ltd
      • 56     MMS Membrane Systems
      • 57     Nikkiso Co. Ltd.
      • 58     Nipro Corporation
      • 59     Nupore Filtration Pvt.Ltd.
      • 60     Parker Hannifin Corporation
      • 61     Porvair plc (Porvair Filtration Group)
      • 62     Powder Systems Limited (PSL)
      • 63     Repligen Corporation
      • 64     SABEU GmbH & Co. KG
      • 65     Saint-Gobain Performance Plastics (ZenPure)
      • 66     Sartorius
      • 67     Shandong Weigao Group Medical Polymer Co. Ltd.
      • 68     Smartflow Technologies
      • 69     Steris Corporation (Cantel Medical Corporation)
      • 70     Sumitomo Bakelite Co., Ltd. (Kawasumi Laboratories Inc.)
      • 71     SunMed
      • 72     Synder Filtration
      • 73     Technofilter
      • 74     Terumo Corporation
      • 75     Thermo Fisher Scientific, Inc.
      • 76     Toray Industries, Inc
      • 77     Trinity Filtration Technologies Pvt. Ltd.
      • 78     Vygon SA
      • 79     Valin Corporation (Rosedale Products Inc.)
      • 80     XENIOS AG
      • 81     YMC America, Process Technologies Group